NASDAQ:NVNO enVVeno Medical (NVNO) Stock Price, News & Analysis $5.95 -0.22 (-3.57%) Closing price 04:00 PM EasternExtended Trading$5.91 -0.04 (-0.67%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOwnershipSEC Filings About enVVeno Medical Stock (NASDAQ:NVNO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get enVVeno Medical alerts:Sign Up Key Stats Today's Range$5.80▼$6.5050-Day Range$6.17▼$11.5552-Week Range$5.80▼$14.66Volume12,092 shsAverage Volume20,941 shsMarket Capitalization$4.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview enVVeno Medical is a medical-device company developing treatments for chronic venous disease, with a focus on deep venous chronic venous insufficiency. This condition can occur when valves in the leg’s deep veins do not function properly, impairing blood flow back to the heart. The company’s lead product, VenoValve, is a bioprosthetic valve designed to restore valve function in affected deep veins. enVVeno has also described a transcatheter valve program, enVVe, intended to provide a less invasive approach to treating the condition. Previously known as Hancock Jaffe Laboratories, the company adopted the enVVeno Medical name in 2021. It is based in Irvine, California, and its development efforts are directed primarily toward the U.S. market.AI Generated. May Contain Errors. Read More enVVeno Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreNVNO MarketRank™: 1.421750663125 of 5 starsenVVeno Medical scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingenVVeno Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageenVVeno Medical has only been the subject of 1 research reports in the past 90 days.Read more about enVVeno Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for enVVeno Medical are expected to grow in the coming year, from ($16.19) to ($6.22) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of enVVeno Medical is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of enVVeno Medical is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioenVVeno Medical has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.07% of the float of enVVeno Medical has been sold short.Short Interest Ratio / Days to CoverenVVeno Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in enVVeno Medical has recently increased by 104.77%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldenVVeno Medical does not currently pay a dividend.Dividend GrowthenVVeno Medical does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.39 News SentimentenVVeno Medical has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for enVVeno Medical this week, compared to 1 article on an average week. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, enVVeno Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $123.00 in company stock.Percentage Held by Insiders14.80% of the stock of enVVeno Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions34.71% of the stock of enVVeno Medical is held by institutions.Read more about enVVeno Medical's insider trading history. Receive NVNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for enVVeno Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVNO Stock News HeadlinesenVVeno Medical to present its enVVE System at annual TCTNovember 2, 2026 | tipranks.comenVVeno Medical Corporation: enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal StudyOctober 30, 2026 | finanznachrichten.deEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 16 at 1:00 AM | Behind the Markets (Ad)enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob BermanOctober 21, 2026 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal TrialOctober 2, 2026 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video SeriesSeptember 16, 2026 | finanznachrichten.deenVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video SeriesSeptember 16, 2026 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-DemandSeptember 11, 2026 | finanznachrichten.deSee More Headlines NVNO Stock Analysis - Frequently Asked Questions How have NVNO shares performed this year? enVVeno Medical's stock was trading at $11.2280 on January 1st, 2026. Since then, NVNO stock has decreased by 46.9% and is now trading at $5.96. How were enVVeno Medical's earnings last quarter? enVVeno Medical Corporation (NASDAQ:NVNO) announced its quarterly earnings results on Thursday, October, 29th. The company reported ($6.29) earnings per share for the quarter, missing the consensus estimate of ($3.27) by $3.02. When did enVVeno Medical's stock split? enVVeno Medical shares reverse split on the morning of Tuesday, January 20th 2026.A 1-35 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 19th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did enVVeno Medical IPO? enVVeno Medical (NVNO) raised $10 million in an IPO on Thursday, May 31st 2018. The company issued 1,500,000 shares at $6.00-$8.00 per share. How do I buy shares of enVVeno Medical? Shares of NVNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of enVVeno Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that enVVeno Medical investors own include Bionano Genomics (BNGO), SNDL (SNDL), ToughBuilt Industries (TBLT), Ampio Pharmaceuticals (AMPE), Avinger (AVGR), Jaguar Animal Health (JAGX) and ObsEva (OBSV). Company Calendar Last Earnings10/29/2026Today11/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (15m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NVNO's financial health is in the Red zone, according to TradeSmith. NVNO has been in this zone for over 15 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NVNO CIK1661053 Webwww.envveno.com Phone(949) 261-2900Fax949-261-2992Employees33Year Founded1987Profitability EPS (Trailing Twelve Months)($17.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$19.47 million Net MarginsN/A Pretax MarginN/A Return on Equity-70.33% Return on Assets-63.60% Debt Debt-to-Equity RatioN/A Current Ratio7.35 Quick Ratio7.35 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$41.38 per share Price / Book0.14Miscellaneous Outstanding Shares690,000Free Float592,000Market Cap$4.11 million OptionableNo Data Beta1.41 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:NVNO) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.